Literature DB >> 17450255

[Fetus radiation doses from nuclear medicine and radiology diagnostic procedures. Potential risks and radiation protection instructions].

Pavlos Markou1.   

Abstract

Although in pregnancy it is strongly recommended to avoid diagnostic nuclear medicine and radiology procedures, in cases of clinical necessity or when pregnancy is not known to the physician, these diagnostic procedures are to be applied. In such cases, counseling based on accurate information and comprehensive discussion about the risks of radiation exposure to the fetus should follow. In this article, estimations of the absorbed radiation doses due to nuclear medicine and radiology diagnostic procedures during the pregnancy and their possible risk effects to the fetus are examined and then discussed. Stochastic and detrimental effects are evaluated with respect to other risk factors and related to the fetus absorbed radiation dose and to the post-conception age. The possible termination of a pregnancy, due to radiation exposure is discussed. Special radiation protection instructions are given for radiation exposures in cases of possible, confirmed or unknown pregnancies. It is concluded that nuclear medicine and radiology diagnostic procedures, if not repeated during the pregnancy, are rarely an indication for the termination of pregnancy, because the dose received by the fetus is expected to be less than 100 mSv, which indicates the threshold dose for having deterministic effects. Therefore, the risk for the fetus due to these diagnostic procedures is low. However, stochastic effects are still possible but will be minimized if the radiation absorbed dose to the fetus is kept as low as possible.

Mesh:

Substances:

Year:  2007        PMID: 17450255

Source DB:  PubMed          Journal:  Hell J Nucl Med        ISSN: 1790-5427            Impact factor:   1.102


  1 in total

1.  Epidemiological survey of 214 families with bladder exstrophy-epispadias complex.

Authors:  L Gambhir; T Höller; M Müller; G Schott; H Vogt; B Detlefsen; A-K Ebert; M Fisch; S Beaudoin; R Stein; S A Boyadjiev; J P Gearhart; W Rösch; B Utsch; T M Boemers; H Reutter; M Ludwig
Journal:  J Urol       Date:  2008-03-04       Impact factor: 7.450

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.